Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiora Pharmaceuticals

3.13
+0.04341.41%
Volume:6.89K
Turnover:20.96K
Market Cap:9.39M
PE:-1.09
High:3.14
Open:2.96
Low:2.96
Close:3.09
Loading ...
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Major Issues Report

8-K - Current report
Oct 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 26, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Major Issues Report

8-K - Current report
Sep 16, 2022

Major Issues Report

8-K - Current report
Aug 25, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 28, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 26, 2022

Major Issues Report

8-K - Current report
Jul 21, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 21, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 19, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 19, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 14, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 13, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]